The Association between Hypoxia-inducible factor-1 α gene C1772T polymorphism and cancer risk: A meta-analysis of 37 case-control studies

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  He, Pengfei ^a   Han, Qi ^a   Liu, Jiajia ^a   Liu, Dongjuan ^a   Zhao, Xin ^a   Hu, Ting ^a   Jiang, Lu ^a   Dan, Hongxia ^a   Zeng, Xin ^a   Li, Jing ^a   Wang, Jiayi ^a   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ALLELE; ARTICLE; ASIAN; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ETHNICITY; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEAD AND NECK CANCER; HIF 1ALPHA GENE; HUMAN; KIDNEY CARCINOMA; PANCREAS CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84893206082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083441     Document Type: Article

References (51)

1. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850-860. doi:10.1038/nrc1476. PubMed: 15516958. (Pubitemid 39472952)
2. Hill RP, Marie-Egyptienne DT, Hedley DW (2009) Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 19: 106-111. doi:10.1016/j.semradonc.2008. 12.002. PubMed: 19249648.
3. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K et al. (2003) Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24: 1779-1783. doi:10.1093/carcin/bgg132. PubMed: 12919954. (Pubitemid 37408141)
4. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M et al. (2010) VHL and HIF signalling in renal cell carcinogenesis. J Pathol 221: 125-138. doi:10.1002/path.2689. PubMed: 20225241.
5. Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Activation of the HIF pathway in cancer. Curr Opin Genet Dev 11: 293-299. doi:10.1016/S0959-437X(00)00193-3. PubMed: 11377966.
6. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr et al. (2002) Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296: 1886-1889. doi:10.1126/science.1073440. PubMed: 12004076. (Pubitemid 34596278)
7. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732. doi:10.1038/nrc1187. PubMed: 13130303.
8. Semenza GL, Shimoda LA, Prabhakar NR (2006) Regulation of gene expression by HIF-1. Novartis Found Symp 272: 14-8; discussion:
9. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60: 6189-6195. PubMed: 11085544.
10. Zhong H, Semenza GL, Simons JW, De Marzo AM (2004) Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 28: 88-93. doi:10.1016/j.cdp.2003.12.009. PubMed: 15068831. (Pubitemid 38448745)
11. Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P (2006) Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45: 833-840. doi:10.1002/mc.20209. PubMed: 16865676.
12. Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S et al. (2005) Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 78: 123-130. doi:10.1016/j.yexmp.2004.11.002. PubMed: 15713437. (Pubitemid 40248793)
13. Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U et al. (2010) Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 49: 805-809. PubMed: 20572162.
14. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M et al. (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015. PubMed: 10945599. (Pubitemid 30636574)
15. Xu G, Wang M, Xie W, Bai X (2011) Hypoxia-inducible factor-1 alpha C1772T gene polymorphism and glioma risk: a hospital-based case-control study from China. Genet Test Mol Biomarkers 15: 461-464. doi:10.1089/gtmb.2010.0265. PubMed: 21329466.
16. Putra AC, Tanimoto K, Arifin M, Hiyama K (2011) Hypoxia-inducible factor-1alpha polymorphisms are associated with genetic aberrations in lung cancer. Respirology 16: 796-802. doi:10.1111/j.1440-1843.2011.01972.x. PubMed: 21435097.
17. Wang X, Liu Y, Ren H, Yuan Z, Li S et al. (2011) Polymorphisms in the hypoxia-inducible factor-1alpha gene confer susceptibility to pancreatic cancer. Cancer Biol Ther 12: 383-387. doi:10.4161/cbt.12.5.15982. PubMed: 21709439.
18. Qin C, Cao Q, Ju X, Wang M, Meng X et al. (2012) The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma. Ann Oncol 23: 981-989. doi:10.1093/annonc/mdr325. PubMed: 21778301.
19. Kuo WH, Shih CM, Lin CW, Cheng WE, Chen SC et al. (2012) Association of hypoxia inducible factor-1alpha polymorphisms with susceptibility to non-small-cell lung cancer. Transl Res 159: 42-50. doi:10.1016/j.trsl.2011.09. 003. PubMed: 22153809.
20. Ruiz-Tovar J, Fernandez-Contreras ME, Martín-Perez E, Gamallo C (2012) Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer. Tumori 98: 364-369. PubMed: 22825513.
21. Mera-Menéndez F, Hinojar-Gutiérrez A, Guijarro RM, de Gregorio JG, Mera-Menéndez E et al. (2013) Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx. Clin Transl Oncol 15: 358-363. PubMed: 22914908.
22. Li P, Cao Q, Shao PF, Cai HZ, Zhou H et al. (2012) Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl 14: 864-869. doi:10.1038/aja.2012.101. PubMed: 23042446.
23. Zagouri F, Sergentanis TN, Gazouli M, Tsigginou A, Dimitrakakis C et al. (2012) HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep 39: 10873-10879. doi:10.1007/s11033-012-1984-2. PubMed: 23065205.
24. Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS et al. (2012) High HIF-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol 4: 87. PubMed: 23296286.
25. Li K, Zhang Y, Dan Z, Wang Y, Ren ZC (2009) Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet 47: 625-634. doi:10.1007/s10528-009-9254-2. PubMed: 19504235.
26. Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C et al. (2009) Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer. Exp Biol Med (Maywood) 234: 1109-1116. doi:10.3181/0902-RM-49. PubMed: 19546348.
27. Naidu R, Har YC, Taib NA (2009) Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer. Neoplasma 56: 441-447. doi:10.4149/neo-2009-05-441. PubMed: 19580347.
28. Chen MK, Chiou HL, Su SC, Chung TT, Tseng HC et al. (2009) The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 45: e222-e226. doi:10.1016/j.oraloncology.2009.07.015. PubMed: 19717330.
29. Hsiao PC, Chen MK, Su SC, Ueng KC, Chen YC et al. (2010) Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 102: 163-169. doi:10.1002/jso.21539. PubMed: 20648588.
30. Shieh TM, Chang KW, Tu HF, Shih YH, Ko SY et al. (2010) Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol 46: e47-e53. doi:10.1016/j.oraloncology.2010.04.009. PubMed: 20656543.
31. Chai D, Chen YL, Zheng A, Liu YY, Chu YX et al. (2010) Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China. Sichuan da Xue Xue Bao Yi Xue Ban 41: 674-677. PubMed: 20848794.
32. Kim YH, Park IA, Park WY, Kim JW, Kim SC et al. (2011) Hypoxia-inducible factor 1alpha polymorphisms and early-stage cervical cancer. Int J Gynecol Cancer 21: 2-7. doi:10.1097/IGC.0b013e318204f6e6. PubMed: 21330825.
33. Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS et al. (2009) The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 8: 118-124. doi:10.4161/cbt.8.2.7086. PubMed: 19106642.
34. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B et al. (2009) Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 16: 2351-2358. doi:10.1245/s10434-009-0503-8. PubMed: 19449077.
35. Ribeiro AL, Gaspar JF, Pereira T, Ribeiro V (2013) Lack of relevance of HIF-1alpha polymorphisms in breast cancer in a Portuguese population. Anticancer Res 33: 2549-2555. PubMed: 23749907.
36. Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ et al. (2005) Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6: 155-158. doi:10.1111/j.1443-9573.2005.00223.x. PubMed: 16246222.
37. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E et al. (2008) Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Arch Med Res 39: 338-345. doi:10.1016/j.arcmed.2007.11.012. PubMed: 18279708. (Pubitemid 351227407)
38. Kim HO, Jo YH, Lee J, Lee SS, Yoon KS (2008) The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep 20: 1181-1187. PubMed: 18949419.
39. Lee JY, Choi JY, Lee KM, Park SK, Han SH et al. (2008) Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta 389: 167-170. doi:10.1016/j.cca.2007.12.005. PubMed: 18160046.
40. Zhao T, Lv J, Zhao J, Nzekebaloudou M (2009) Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis. J Exp Clin Cancer Res 28: 159. doi:10.1186/1756-9966-28-159. PubMed: 20035632.
41. Wang J, Jin X, Wang H, Yang J, Wang L et al. (2013) The -308G/A polymorphism of the tumor necrosis factor-alpha gene is associated with the risk of upper aerodigestive tract cancer: a meta-analysis. Tohoku J Exp Med 229: 245-254. doi:10.1620/tjem.229.245. PubMed: 23594457.
42. Zintzaras E, Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61: 634-645. doi:10.1016/j.jclinepi. 2007.12.011. PubMed: 18538260. (Pubitemid 351766746)
43. Agúndez JA (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9: 520-531. doi:10.2174/138920008784892083. PubMed: 18680472.
44. Konac E, Onen HI, Metindir J, Alp E, Biri AA et al. (2007) An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev 31: 102-109. doi:10.1016/j.cdp.2007.01.001. PubMed: 17418979. (Pubitemid 46680371)
45. Fu XS, Choi E, Bubley GJ, Balk SP (2005) Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63: 215-221. doi:10.1002/pros.20190. PubMed: 15538748. (Pubitemid 40571055)
46. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013. PubMed: 21376230.
47. Spinola M, Conti B, Ravagnani F, Fabbri A, Incarbone M et al. (2004) A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis. Eur J Cancer Prev 13: 87-89. doi:10.1097/00008469-200402000-00014. PubMed: 15075794. (Pubitemid 38328125)
48. Ribeiro AL, Correia J, Ribeiro V (2009) Ethnic variability of HIF-1alpha polymorphisms. Cancer Biomark 5: 273-277. PubMed: 20037203.
49. Hua K, Din J, Cao Q, Feng W, Zhang Y et al. (2009) Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep 21: 893-898. PubMed: 19287985.
50. Kazi AA, Jones JM, Koos RD (2005) Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol 19: 2006-2019. doi:10.1210/me.2004-0388. PubMed: 15774498. (Pubitemid 41130691)
51. Schaid DJ, Jacobsen SJ (1999) Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 149: 706-711. doi:10.1093/oxfordjournals.aje.a009878. PubMed: 10206619. (Pubitemid 29180778)